ATM and diffuse large B-cell lymphoma: In the aggregate these data provide a foundation for novel therapeutic strategies that can be targeted independently of the DDR pathway in ATM-deficient subset of DLBCL, A-T patients, and elderly patients with DLBCL where ATM expression is low.